TaiGen Biotechnology Overview

  • Founded
  • 2001
Founded
  • Status
  • Public
  • Employees
  • 51
Employees
  • Stock Symbol
  • 4157
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.68
  • (As of Monday Closing)

TaiGen Biotechnology General Information

Description

TaiGen Biopharmaceuticals Holdings Ltd is engaged in the healthcare domain. It is engaged in the development of novel therapeutics for infectious diseases, cancer, and diabetes-related complications. Its product pipeline includes Taigexyn (Nemonoxacin), a novel non-fluorinated quinolone antibacterial drug for the treatment of bacterial infections. The company's development projects comprise Nemonoxacin for treating community-acquired pneumonia and diabetic foot infection, Burixafor, and Furaprevir.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Stock Exchange
ROCO
Primary Office
  • 7th Floor, 138 Shin Ming Road
  • Neihu District
  • Taipei, 114
  • Taiwan
+886 02 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TaiGen Biotechnology Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.68 $0.68 $0.59 - $0.94 $484M 717M 2.16M -$0.02

TaiGen Biotechnology Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 625,757 573,536 418,181 369,695
Revenue 2,289 796 657 982
EBITDA (12,018) (12,853) (8,526) (11,680)
Net Income (13,001) (13,753) (9,569) (11,377)
Total Assets 16,102 19,949 31,590 38,835
Total Debt 439 614 2,210 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

TaiGen Biotechnology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore TaiGen Biotechnology‘s full profile, request access.

Request a free trial

TaiGen Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
TaiGen Biopharmaceuticals Holdings Ltd is engaged in the healthcare domain. It is engaged in the development of novel th
Drug Discovery
Taipei, Taiwan
51 As of 2014
00000
0.000 0000-00-00
00000000 00000

000000 0

lum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa q
0000000000000
Foster City, CA
00000 As of 0000
00.000
000000&0

0000 000

elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qu
000000000000000
Stamford, CT
00 As of 0000
00000
0.000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TaiGen Biotechnology Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gilead Sciences Formerly VC-backed Foster City, CA 00000 00.000 000000&0
0000 00000000 Formerly VC-backed Stamford, CT 00 00000 000000&0 00000
00000000 Corporation Berkeley Heights, NJ 00 000.00 000000&0
0000000 000000 Venture Capital-Backed Solna, Sweden 00 000.00 0000000000 0 000.00
000000000 Formerly VC-backed South San Francisco, CA 00000 000.00 00000000000
To view TaiGen Biotechnology’s complete competitors history, request access »

TaiGen Biotechnology Executive Team (1)

Name Title Board Seat Contact Info
Ming-Chu Hsu Ph.D Chief Executive Officer, Chairman of the Board, President & Founder
To view TaiGen Biotechnology’s complete executive team members history, request access »

TaiGen Biotechnology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TaiGen Biotechnology Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000 00000 10-Jan-2017 00000 0000000 Pharmaceuticals
To view TaiGen Biotechnology’s complete investments history, request access »